Labcorp (LH) Tops Q3 EPS by 1c; Offers FY22 EPS Guidance
Tweet
Share
E-mail
Get Alerts LH Hot Sheet
Price: $321.31 -1.71%
EPS Growth %: +11.2%
Financial Fact:
Net sales: 2.37B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +11.2%
Financial Fact:
Net sales: 2.37B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Labcorp (NYSE: LH) reported Q3 EPS of $4.68, $0.01 better than the analyst estimate of $4.67. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.8 billion.
GUIDANCE:
Labcorp sees FY2022 EPS of $19.25-$20.25, versus the consensus of $20.19.
For earnings history and earnings-related data on Labcorp (LH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Labcorp acquires MLM Medical Labs to expand lab network
- Freeport-McMoRan shares surge as copper hits record $14,694/ton
- MSC Industrial names Rob Kuhns as executive VP and CFO
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
